Cel-Sci
CVM
#9791
Rank
HK$0.38 B
Marketcap
HK$45.31
Share price
-1.19%
Change (1 day)
-50.31%
Change (1 year)

Cel-Sci (CVM) - Total debt

Total debt on the balance sheet as of September 2025 : HK$73.31 Million

According to Cel-Sci 's latest financial reports the company's total debt is HK$73.31 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Cel-Sci - Total debt on balance sheet (from 1996 to 2025)

Total debt by year

Year Total debt Change
2025-09-30HK$73.02 M-19.17%
2024-09-30HK$90.34 M-14.99%
2023-09-30HK$0.10 B-11.53%
2022-09-30HK$0.12 B-3.4%
2021-09-30HK$0.12 B15.14%
2020-09-30HK$0.10 B2.01%
2019-09-30HK$0.10 B1.09%
2018-09-30HK$0.10 B-5.59%
2017-09-30HK$0.11 B9.94%
2016-09-30HK$0.10 B-6.23%
2015-09-30HK$0.10 B1135.84%
2014-09-30HK$8.7 M-0.91%
2013-09-30HK$8.78 M2.67%
2012-09-30HK$8.56 M-78.02%
2011-09-30HK$38.94 M354.6%
2010-09-30HK$8.56 M-0.17%
2009-09-30HK$8.58 M452.41%
2008-09-30HK$1.55 M
2005-09-30HK$0.02 M-0.45%
2004-09-30HK$0.02 M-99.65%
2003-09-30HK$6.76 M-51.09%
2002-09-30HK$13.83 M5584.11%
2001-09-30HK$0.24 M25.84%
2000-09-30HK$0.19 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Johnson & Johnson
JNJ
HK$357.78 B 487,916.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
HK$426.47 B 581,609.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
HK$0.54 B 638.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Curis
CRIS
HK$15.37 M-79.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
HK$133.38 B 181,839.28%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
BioCryst Pharmaceuticals
BCRX
HK$5.04 B 6,777.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
HK$5.18 B 6,966.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
HK$4.31 M-94.12%๐Ÿ‡บ๐Ÿ‡ธ USA